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Background Findings Findings (cont.) Discussion
Cancer prevalence continues to rise. In vitro and in vivo studies 
have demonstrated that opioid receptor agonists may be 
associated with poor outcomes for cancer patients. Laboratory 
studies have shown that opioids cause immunosuppression; 
tumor cell progression, recurrence and metastasis. The surgical 
environment further decreases immune function, causes an 
inflammatory response and promotes cancer cell mobilization. 
Anesthesia providers are in a unique position to influence 
postoperative outcomes. Opioid free anesthetic delivery is a 
growing trend amongst anesthesia providers and is supported by 
the literature. 
The purpose of this project is to compare intraoperative opioid 
administration rates for patients with a cancer diagnosis to those 
without a cancer diagnosis. 
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ReferencesMethods
• Design: Observational, retrospective, descriptive study 
• Regulatory: CIRC approval and IRB exemption 
• Dates: October 1, 2017 to September 30, 2018
• Protection of human subjects: Deidentified patient data stored 
in HIPPA compliant Redcap Database
• Setting: Providence Sacred Heart Medical Center
• Participants: Adult, non-emergent surgical patients receiving IV 
and inhalational anesthesia
• Event rates reported as risk and relative risk (RR) calculated
• Analysis: Group differences in categorical variables tested by 
Chi-Square 
This project determined that rates of intraoperative opioid 
administration were similar for patients with or without a 
cancer diagnosis. Literature suggests the use of opioid 
free anesthesia should be considered for patients with a 
cancer diagnosis. Opioid administration is common 
practice. Reducing its use may provide improved short and 
long term outcomes.
This project did not consider costs of various anesthesia 
techniques nor did it examine dosages of opioid 
administration. Future research should examine reductions 
in the use of opioid administration and the costs 
associated with the use of opioid free anesthesia. 
• A vast majority of patients undergoing surgery with a cancer 
diagnosis receive intraoperative opioids
• Rates of intraoperative opioid administration were similar for patients with 
and without a cancer diagnosis
• TIVA was not performed for any patients with a cancer diagnosis
• Cancer patients with case durations lasting longer than the median 
were 10% more likely to receive intraoperative opioids









Intravenous Anesthesia 590 7%
Inhalational Agent 7578 93%











Age (years 60.6 15.8
Body Mass Index (kg/m2) 29.9 7.2
Median IQR
Case Duration (minutes)* 147 102-238
Table 1. Baseline Demographic & Characteristics N=8168
* Anesthesia Start to Finish
7%
Figure 1. Project Participants by Cancer Diagnosis
Received Intraoperative Opioids




Yes No Risk RR 95% CI P
Yes 899 62 93.5% 1.00 0.98-1.02 0.97
No 6744 463 93.6%
Table 2. Use of Intraoperative Opioids by Cancer Diagnosis
Intraoperative Opioid Use
History of Opioid Use Yes No Risk RR 95% CI P
Yes 78 3 96.3% 1.03 0.99-1.08 0.18
No 821 59
Surgery Duration Yes No Risk RR 95% CI P
Above Median 486 11 98% 1.10 1.06-1.14 <0.001
Below Median 413 51 89%




Inhalational 899 62 94%
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Cancer Diagnosis No Cancer Diagnosis
Intraoperative Opioid Use
Cancer Diagnosis Yes No Risk RR 95% CI P
Yes 899 62 93.5% 1.00 0.98-1.02 0.97
No 6744 463 93.6%
Table 2. Use of Intraoperative Opioids by Cancer Diagnosis
Intraoperative Opioid Use
History of Opioid Use Yes No Risk RR 95% CI P
Yes 78 3 96.3% 1.03 0.99-1.08 0.18
No 821 59
Surgery Duration Yes No Risk RR 95% CI P
Above Median 486 11 98% 1.10 1.06-1.14 <0.001
Below Median 413 51 89%
Anesthesia Type Yes No Risk RR 95% CI P
Intravenous Anesthesia 0 0 0%
Inhalational 899 62 94%
Table 3. Use of Intraoperative Opioids by Other Risk Factors (Cancer Diagnosis Only)
Service Line Received Intraoperative Opioids Did Not Receive Intraoperative Opioids Risk
Orthopedics 1792 152 92%
Neurosurgery 1235 12 99%
Cardiothoracic 982 5 99%
General 884 47 95%
Vascular 582 16 97%
Cardiology 435 22 95%
